The rationale for these findings can be found in the coactivation of the RAS/MAPK and PI3K-Akt-mTOR signalling pathways, frequently occurring in human malignancies, including PCa (Figure 2). The gene discussed is AKT1; the disease is posterior cortical atrophy.